Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era.

ABSTRACT:

Importance

Men with limited life expectancy (LE) have historically been overtreated for prostate cancer despite clear guideline recommendations. With increasing use of active surveillance, it is unclear if overtreatment of men with limited LE has persisted and how overtreatment varies by tumor risk and treatment type.

Objective

To determine if rates of overtreatment of men with limited LE have persisted in the active surveillance era and whether overtreatment varies by tumor risk or treatment type.

Design, setting, and participants

This cohort study included men with clinically localized prostate cancer in the Veterans Affairs health system who received a diagnosis between January 1, 2000, and December 31, 2019.

Main outcomes and measures

LE was estimated using

SUBMITTER: Daskivich TJ 

PROVIDER: S-EPMC11555577 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature